Ergomed Acquires ADAMAS Consulting Group
February 9, 2022
Ergomed plc has acquired ADAMAS Consulting Group Limited for a cash consideration of £25.6 million (enterprise value £24.2m), adding a specialist regulatory compliance and quality assurance capability to its pharmaceutical services offering. ADAMAS, which recorded £8.5m revenue and £1.8m adjusted EBITDA in 2021, will continue to operate independently with its senior management retained and is expected to be immediately accretive to Ergomed's earnings while expanding the Group's global reach.
- Buyers
- Ergomed plc
- Targets
- ADAMAS Consulting Group Limited
- Industry
- Healthcare Services
- Location
- United Kingdom
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
athagoras Acquires DiaMed Beratungsgesellschaft für pharmazeutische Unternehmen mbH
October 16, 2025
Healthcare Services
athagoras has acquired DiaMed Beratungsgesellschaft für pharmazeutische Unternehmen mbH, a German consultancy specialising in Regulatory Affairs and Pharmacovigilance, to strengthen its RA/PV capabilities and expand local capacity in Germany. The deal adds DiaMed's experienced team to athagoras' European life‑sciences services platform and complements existing operations including CSO Pharma and S-cubed.
-
The VERTEX Companies Acquires ADAMS Management Services
August 5, 2025
Healthcare Services
The VERTEX Companies, LLC (a Wind Point Partners portfolio company) has acquired ADAMS Management Services Corporation, a healthcare-focused program and project management firm headquartered in Rome, Georgia. The add-on expands VERTEX's healthcare program management capabilities and national reach, integrating ADAMS' nearly four decades of experience into VERTEX's multidisciplinary professional services platform.
-
Danforth Advisors Acquires Advyzom
September 10, 2024
Healthcare Services
Danforth Advisors has acquired Advyzom, a New Jersey–based regulatory affairs consultancy of approximately 30 specialists, expanding Danforth's clinical and regulatory capabilities to offer a comprehensive suite of services for life science companies. The acquisition integrates Advyzom's regulatory strategy, FDA liaison, medical writing, and submissions expertise into Danforth's platform to better support clients across development, approval, and market entry.
-
Kymanox Acquires Agilis Consulting Group
March 24, 2023
Healthcare Services
Kymanox, a PE-backed life sciences professional services firm, has acquired Agilis Consulting Group, a Cincinnati-based human factors and usability engineering consultancy. The transaction (terms undisclosed) expands Kymanox's human factors, regulatory strategy, and usability engineering capabilities to support medical device, combination product, and biologics clients globally.
-
Supernus Pharmaceuticals Acquires Adamas Pharmaceuticals
October 11, 2021
Pharmaceuticals
Supernus Pharmaceuticals agreed to acquire Adamas Pharmaceuticals in a cash tender offer valued at approximately $400 million upfront plus up to $50 million in contingent value rights, for total consideration of about $450 million. The acquisition gives Supernus two marketed CNS products (GOCOVRI and Osmolex ER), diversifies its Parkinson’s disease portfolio and is expected to be accretive with material synergies in 2022.
-
Ergomed plc Acquires MS Clinical Services (MedSource)
December 14, 2020
Healthcare Services
Ergomed plc has acquired MS Clinical Services, LLC (MedSource), a Houston-based full-service CRO specializing in oncology and rare disease, for an initial $16.2 million in cash plus potential shares and contingent consideration. The acquisition expands Ergomed's US footprint (adding ~110 US employees and offices in Houston, Raleigh and Boston), strengthens its specialist clinical research capabilities and is expected to be immediately accretive.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.